Not all multiplex immunofluorescence technologies are designed for the same objective. This guide compares the main categories and explains which workflows are best for discovery, biomarker development, and clinical research. buff.ly/IG6Pwv0

How can clinical research pharmacies scale more efficiently? Discover how the University of Florida’s IDS Pharmacy increased protocol capacity by 51.7% while streamlining workflows and maintaining compliance. Read the case study. buff.ly/HOH3KbG

Gene‑modified CAR T cell therapies are transforming cancer treatment, but variability and manufacturing challenges remain. Discover high‑throughput strategies to characterize CAR T cells—activation, memory, exhaustion, cytokines, and killing. buff.ly/UvjkAwK

Eli Lilly is cracking down on black-market sales of retatrutide, its experimental obesity drug that has not yet been approved for human use. buff.ly/KB2cWS0

The FDA has approved pritelivir, a new oral treatment for difficult-to-treat herpes simplex virus infections in adults with weakened immune systems. buff.ly/o6u9dTK

Your reporter deserves a real control. FluoroCytes™ from Slingshot Bio carry the authentic fluorescent protein. Not a dye. Four gateable populations in one vial. eGFP, SYFP2, tdTomato available now. Research Use Only. buff.ly/oaLMOlY

Looking to modernize your pharmaceutical QA/QC lab? Discover practical ways to simplify workflows, improve processes, and prepare for future technologies with this helpful guide. buff.ly/LDpLIvu

Teva wins FDA approval for Weltruza, the first once-monthly subcutaneous olanzapine injection for adults with schizophrenia. buff.ly/LbewnXO

Pfizer’s Tukysa wins FDA approval for first-line maintenance treatment of HER2-positive metastatic breast cancer. buff.ly/0cr2xSG

Not all multiplex immunofluorescence technologies are designed for the same objective. This guide compares the main categories and explains which workflows are best for discovery, biomarker development, and clinical research. buff.ly/6xVZBFh

A new laser-based technique detects the colorectal cancer biomarker CEACAM-5 in blood plasma within minutes, offering much faster results than conventional methods. buff.ly/wUkEBh3

Modernizing a pharma QA/QC laboratory is about more than replacing a LIMS. Discover how to reduce complexity, standardize processes, prepare for AI and emerging technologies, and build a foundation for long-term value in this new practical guide. buff.ly/F12KTiq

Testing guidelines are clear. Participation is not. A look at how standardized first-void urine as an at-home collected specimen is extending molecular STI laboratory testing beyond the clinic — without compromising what the laboratory receives. buff.ly/onzxyIO

Otsuka ICU Medical recalls a lot of sodium chloride injection after a potassium chloride product was found inside saline-labeled packaging. buff.ly/FIxShqQ

The FDA has approved lirafugratinib (Lyrfigtu) for previously treated advanced cholangiocarcinoma with FGFR2 fusions or rearrangements. buff.ly/I603iRj

Discover how genetic analysis technologies are helping biopharmaceutical organizations optimize clinical trials, improve patient stratification, and accelerate drug development. buff.ly/n1lHkFs

Traceability is no longer just about compliance. In today's distributed research environment, the ability to demonstrate specimen history, context, and chain of custody may be key to building sponsor confidence and supporting future scientific value. buff.ly/4Qg0T6K

⚛️ See how single-particle nano-flow cytometry reveals hidden heterogeneity in nanoparticle formulations, from cargo loading to surface-ligand density. 📅 Sept 29 | 11 AM PT / 2 PM EDT 👉 Register: buff.ly/nsIuWb9

⚙️ See how the OptiMATE Gradient Maker automates gradient prep for DGUC, cutting run time & manual effort across research and process-scale workflows. 📅 Sept 29 | 9 AM PT / 12 PM ET 👉 Register: buff.ly/6YWsTtr

Bringing a diagnostic test to market takes more than scientific innovation. Explore the reimbursement, evidence, coding, coverage, and payment strategies that support successful adoption in the US. buff.ly/SN7fRZ3